Cubresa is once again pleased to take part in ISMRM. Please join us at the technical exhibition at booth 1011. If you would like to book at meeting in advance, please contact Lisa Bako at lbako@cubresa.com, or by phone at
ISMRM 2019 in Montreal
Cubresa selects distributor for preclinical line of PET inserts in China
Winnipeg, MB – February 25th, 2019 – Cubresa Inc., a world leader in PET inserts for MRI, has selected a Chinese distributor for its NuPET™ preclinical imaging product line. Cubresa is pleased to announce that it has signed an agreement
Cubresa Developing BrainPET Insert Through Joint Venture in China
Winnipeg, MB – January 29th, 2019 – Cubresa Inc., a world leader in PET inserts for MRI, is expanding into the clinical marketplace with the announcement of a joint venture in Hefei, China. Together with the GaoXin Group and private
Imaging in 2020 – Wyoming
Cubresa is pleased to attend the Imaging in 2020 conference at the Jackson Lake Lodge in the Grand Teton National Park, Wyoming. For more information concerning the event, please click here. http://www.imagingin2020.com
WMIC 2018 in Seattle
Please join Cubresa at the World Molecular Imaging Congress in Seattle, Washington this September. If you would like to book at meeting in advance, please contact Lisa Bako at lbako@cublocal.azurewebsites.net, or by phone at 1.204.798.4579. For more information click here. See you
ISMRM 2018 in Paris
Cubresa is once again pleased to take part in ISMRM. Please join us at the technical exhibition at booth 505. If you would like to book at meeting in advance, please contact Lisa Bako at lbako@cublocal.azurewebsites.net, or by phone at
MPIC 2018 in St. Louis
Please join Cubresa May 6th to 8th in St. Louis, Missouri. We are pleased to take part in the 4th annual meeting and look forward to meeting the attendees. For more information, click here.
Webinar on Wed, July 12: Introducing hybrid preclinical PET/MRI for simultaneous molecular & functional imaging to your lab
Contact us if you missed our webinar on Wednesday, July 12th where we described how Cubresa’s NuPET™ MR-compatible scanner and an existing MRI enable simultaneous preclinical hybrid imaging to better understand disease and to monitor novel treatments in small-animal models. This webinar included: Benefits of
Cubresa SPECT Scanner Used for Evaluation of Alzheimer’s Disease Molecular Label in vivo
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal
Webinar: Greater than the Sum
Simultaneous imaging with complementary modalities: PET & MRI If you missed our free webinar on Thursday, November 10th, you can request a link to view the recording, where you can learn how PET and MRI complement each other, and how